The role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancer

Nutrients

Volumn 6, Issue 11, 2014, Pages 5184-5223

  Liu, Jiajie ^a   Ma, David W L ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Breast cancer (BC); Docosahexaenoic acid (DHA); Eicosapentaenoic acid (EPA); Mammary gland; N 3 polyunsaturated fatty acids (PUFA); linolenic acid (ALA)

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; LINOLENIC ACID;

APOPTOSIS; BIOSYNTHESIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CELL MEMBRANE; CELL PROLIFERATION; FOOD INTAKE; GENE OVEREXPRESSION; HUMAN; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BREAST NEOPLASMS; CLINICAL TRIAL (TOPIC); DISEASE MODEL; DRUG SCREENING; FEMALE;

ALPHA-LINOLENIC ACID; ANIMALS; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84908265851     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6115184     Document Type: Review

References (155)

1. DeSantis, C.; Ma, J.; Bryan, L.; Jemal, A. Breast cancer statistics, 2013. CA Cancer J. Clin.2014, 64, 52–62.
2. Canadian Cancer Statistics. Canadian Cancer Society’s Advisory; Canadian Cancer statistics: Toronto, ON, Canada, 2013.
3. Gerber, M. Omega-3 fatty acids and cancers: A systematic update review of epidemiological studies. Br. J. Nutr.2012, 107(Suppl. 2), S228-S239.
4. Iwasaki, M.; Tsugane, S. Risk factors for breast cancer: Epidemiological evidence from Japanese studies. Cancer Sci. 2011, 102, 1607-1614.
5. Menendez, J.A.; Lupu, R.; Colomer, R. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. Eur. J. Cancer Prev.2005, 14, 263-270.
6. Ravacci, G.R.; Brentani, M.M.; Tortelli, T., Jr.; Torrinhas, R.S.; Saldanha, T.; Torres, E.A.; Waitzberg, D.L. Lipid raft disruption by docosahexaenoic acid induces apoptosis in transformed human mammary luminal epithelial cells harboring HER-2 overexpression. J. Nutr. Biochem.2013, 24, 505-515.
7. Zheng, J.S.; Hu, X.J.; Zhao, Y.M.; Yang, J.; Li, D. Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: Meta-analysis of data from 21 independent prospective cohort studies. BMJ 2013, 346, doi:10.1136/bmj.f3706.
8. Simopoulos, A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother.2002, 56, 365-379.
9. Saadatian-Elahi, M.; Norat, T.; Goudable, J.; Riboli, E. Biomarkers of dietary fatty acid intake and the risk of breast cancer: A meta-analysis. Int. J. Cancer 2004, 111, 584-591.
10. Boyd, N.F.; Stone, J.; Vogt, K.N.; Connelly, B.S.; Martin, L.J.; Minkin, S. Dietary fat and breast cancer risk revisited: A meta-analysis of the published literature. Br. J. Cancer2003, 89, 1672-1685.
11. Anderson, B.M.; Ma, D.W. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis. 2009, 8, 33.
12. Zou, Z.; Bidu, C; Bellenger, S.; Narce, M.; Bellenger, J. n-3 polyunsaturated fatty acids and HER2-positive breast cancer: Interest of the fat-1 transgenic mouse model over conventional dietary supplementation. Biochimie2014, 96, 22-27.
13. Murray, M. ω-3 Polyunsaturated fatty acids and their metabolites as inhibitors of mammalian tumorigenesis. Phytochem. Rev.2014, 13, 139-156.
14. Akhtar, S.; Ismail, T.; Riaz, M. Flaxseed—A miraculous defense against some critical maladies. Pak. J. Pharm. Sci.2013, 26, 199-208.
15. Kris-Etherton, P.M.; Harris, W.S.; Appel, L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation2002, 106, 2747-2757.
16. Institute of Medicine of the National Academies. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids; The National Academies Press: Washington, DC, USA, 2005.
17. Vannice, G.; Rasmussen, H. Position of the academy of nutrition and dietetics: Dietary fatty acids for healthy adults. J. Acad. Nutr. Diet.2014, 114, 136-153.
18. Bagga, D.; Anders, K.H.; Wang, H.J.; Glaspy, J.A. Long-chain n-3-to-n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer. Nutr. Cancer2002, 42, 180-185.
19. Chajes, V.; Torres-Mejia, G.; Biessy, C.; Ortega-Olvera, C.; ngeles-Llerenas, A.; Ferrari, P.; Lazcano-Ponce, E.; Romieu, I. omega-3 and omega-6 Polyunsaturated fatty acid intakes and the risk of breast cancer in Mexican women: Impact of obesity status. Cancer Epidemiol. Biomark. Prev.2012, 21, 319–326.
20. Rose, D.P.; Connolly, J.M.; Rayburn, J.; Coleman, M. Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J. Natl. Cancer Inst.1995, 87, 587–592.
21. Leslie, M.A.; Abdelmagid, S.A.; Perez, K.; Muller, W.J.; Ma, D.W. Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model. Lipids Health Dis. 2014, 13, 96.
22. Schley, P.D.; Brindley, D.N.; Field, C.J. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J. Nutr. 2007, 137, 548–553.
23. Silva, V.; Barazzoni, R.; Singer, P. Biomarkers of fish oil omega-3 polyunsaturated fatty acids intake in humans. Nutr. Clin. Pract.2014, 29, 63–72.
24. Ziegler, R.G.; Hoover, R.N.; Pike, M.C.; Hildesheim, A.; Nomura, A.M.; West, D.W.; Wu-Williams, A.H.; Kolonel, L.N.; Horn-Ross, P.L.; Rosenthal, J.F. et al. Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer Inst.1993, 85, 1819–1827.
25. Singh, G.K.; Hiatt, R.A. Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979–2003. Int. J. Epidemiol.2006, 35, 903–919.
26. Manna, S.; Janarthan, M.; Ghosh, B.; Rana, B.; Rana, A.; Chatterjee, M. Fish oil regulates cell proliferation, protect DNA damages and decrease HER-2/neu and c-Myc protein expression in rat mammary carcinogenesis. Clin. Nutr.2010, 29, 531–537.
27. Manna, S.; Chakraborty, T.; Ghosh, B.; Chatterjee, M.; Panda, A.; Srivastava, S.; Rana, A.; Chatterjee, M. Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7,12-dimethylbenz(α)anthracene-induced mammary carcinogenesis in rats. Prostaglandins Leukot. Essent. Fatty Acids2008, 79, 5–14.
28. Manna, S.; Chakraborty, T.; Damodaran, S.; Samanta, K.; Rana, B.; Chatterjee, M. Protective role of fish oil (Maxepa) on early events of rat mammary carcinogenesis by modulation of DNA-protein crosslinks, cell proliferation and p53 expression. Cancer Cell Int. 2007, 7, 6.
29. Su, H.M.; Hsieh, P.H.; Chen, H.F. A maternal high n-6 fat diet with fish oil supplementation during pregnancy and lactation in rats decreases breast cancer risk in the female offspring. J. Nutr. Biochem.2010, 21, 1033–1037.
30. Hardman, W.E.; Avula, C.P.; Fernandes, G.; Cameron, I.L. Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin. Cancer Res.2001, 7, 2041–2049.
31. Larsson, S.C.; Kumlin, M.; Ingelman-Sundberg, M.; Wolk, A. Dietary long-chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am. J. Clin. Nutr.2004, 79, 935–945.
32. Terry, P.D.; Rohan, T.E.; Wolk, A. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: A review of the epidemiologic evidence. Am. J. Clin. Nutr.2003, 77, 532–543.
33. Stoll, B.A. n-3 fatty acids and lipid peroxidation in breast cancer inhibition. Br. J. Nutr. 2002, 87, 193–198.
34. MacLennan, M.; Ma, D.W. Role of dietary fatty acids in mammary gland development and breast cancer. Breast Cancer Res. 2010, 12, 211.
35. Wakai, K.; Tamakoshi, K.; Date, C.; Fukui, M.; Suzuki, S.; Lin, Y.; Niwa, Y.; Nishio, K.; Yatsuya, H.; Kondo, T. et al. Dietary intakes of fat and fatty acids and risk of breast cancer: A prospective study in Japan. Cancer Sci. 2005, 96, 590–599.
36. Gago-Dominguez, M.; Yuan, J.M.; Sun, C.L.; Lee, H.P.; Yu, M.C. Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese Health Study. Br. J. Cancer2003, 89, 1686–1692.
37. Murff, H.J.; Shu, X.O.; Li, H.; Yang, G.; Wu, X.; Cai, H.; Wen, W.; Gao, Y.T.; Zheng, W. Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: A prospective cohort study. Int. J. Cancer 2011, 128, 1434–1441.
38. Shannon, J.; King, I.B.; Lampe, J.W.; Gao, D.L.; Ray, R.M.; Lin, M.G.; Stalsberg, H.; Thomas, D.B. Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China. Am. J. Clin. Nutr.2009, 89, 265–276.
39. Kim, J.; Lim, S.Y.; Shin, A.; Sung, M.K.; Ro, J.; Kang, H.S.; Lee, K.S.; Kim, S.W.; Lee, E.S. Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: A case-control study. BMC Cancer 2009, 9, 216.
40. Brasky, T.M.; Lampe, J.W.; Potter, J.D.; Patterson, R.E.; White, E. Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol. Biomark. Prev.2010, 19, 1696–1708.
41. Goodstine, S.L.; Zheng, T.; Holford, T.R.; Ward, B.A.; Carter, D.; Owens, P.H.; Mayne, S.T. Dietary (n-3)/(n-6) fatty acid ratio: Possible relationship to premenopausal but not postmenopausal breast cancer risk in U.S. women. J. Nutr.2003, 133, 1409–1414.
42. Thiebaut, A.C.; Chajes, V.; Gerber, M.; Boutron-Ruault, M.C.; Joulin, V.; Lenoir, G.; Berrino, F.; Riboli, E.; Benichou, J.; Clavel-Chapelon, F. Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int. J. Cancer2009, 124, 924–931.
43. Stripp, C.; Overvad, K.; Christensen, J.; Thomsen, B.L.; Olsen, A.; Moller, S.; Tjonneland, A. Fish intake is positively associated with breast cancer incidence rate. J. Nutr.2003, 133, 3664–3669.
44. Witt, P.M.; Christensen, J.H.; Schmidt, E.B.; Dethlefsen, C.; Tjonneland, A.; Overvad, K.; Ewertz, M. Marine n-3 polyunsaturated fatty acids in adipose tissue and breast cancer risk: A case-cohort study from Denmark. Cancer Causes Control2009, 20, 1715–1721.
45. Maillard, V.; Bougnoux, P.; Ferrari, P.; Jourdan, M.L.; Pinault, M.; Lavillonniere, F.; Body, G.; Le, F.O.; Chajes, V. n-3 and n-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. Int. J. Cancer2002, 98, 78–83.
46. Kuriki, K.; Hirose, K.; Wakai, K.; Matsuo, K.; Ito, H.; Suzuki, T.; Hiraki, A.; Saito, T.; Iwata, H.; Tatematsu, M. et al. Breast cancer risk and erythrocyte compositions of n-3 highly unsaturated fatty acids in Japanese. Int. J. Cancer2007, 121, 377-385.
47. Shannon, J.; King, I.B.; Moshofsky, R.; Lampe, J.W.; Gao, D.L.; Ray, R.M.; Thomas, D.B. Erythrocyte fatty acids and breast cancer risk: A case-control study in Shanghai, China. Am. J. Clin. Nutr. 2007, 85, 1090-1097.
48. Patterson, R.E.; Flatt, S.W.; Newman, V.A.; Natarajan, L.; Rock, C.L.; Thomson, C.A.; Caan, B.J.; Parker, B.A.; Pierce, J.P. Marine fatty acid intake is associated with breast cancer prognosis. J. Nutr.2011, 141, 201-206.
49. Signori, C; DuBrock, C; Richie, J.P.; Prokopczyk, B.; Demers, L.M.; Hamilton, C; Hartman, T.J.; Liao, J.; El-Bayoumy, K.; Manni, A. Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: Interim feasibility and biomarkers analysis from a clinical trial. Eur. J. Clin. Nutr.2012, 66, 878-884.
50. Thompson, L.U.; Chen, J.M.; Li, T.; Strasser-Weippl, K.; Goss, P.E. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin. Cancer Res.2005, 11, 3828-3835.
51. Menendez, J.A.; Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer2007, 7, 763-777.
52. Gu, Z.; Suburu, J.; Chen, H.; Chen, Y.Q. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. Biomed. Res. Int. 2013, 2013, doi:10.1155/2013/824563.
53. Wassall, S.R.; Stillwell, W. Docosahexaenoic acid domains: The ultimate non-raft membrane domain. Chem. Phys. Lipids2008, 153, 57-63.
54. Chenais, B.; Blanckaert, V. The Janus face of lipids in human breast cancer: How polyunsaturated Fatty acids affect tumor cell hallmarks. Int. J. Breast Cancer 2012, 2012, doi: 10.1155/2012/712536.
55. Murai, T. The role of lipid rafts in cancer cell adhesion and migration. Int. J. Cell Biol. 2012, 2012, doi:10.1155/2012/763283.
56. Rogers, K.R.; Kikawa, K.D.; Mouradian, M.; Hernandez, K.; McKinnon, K.M.; Ahwah, S.M.; Pardini, R.S. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis2010, 31, 1523-1530.
57. Ma, D.W.; Seo, J.; Davidson, L.A.; Callaway, E.S.; Fan, Y.Y.; Lupton, J.R.; Chapkin, R.S. n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J. 2004, 18, 1040-1042.
58. Burdge, G.C.; Calder, P.C. Conversion of α-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod. Nutr. Dev.2005, 45, 581-597.
59. Young, L.R.; Kurzer, M.S.; Thomas, W.; Redmon, J.B.; Raatz, S.K. Effect of dietary fat and omega-3 fatty acids on urinary eicosanoids and sex hormone concentrations in postmenopausal women: A randomized controlled feeding trial. Nutr. Cancer2011, 63, 930-939.
60. Healy, D.A.; Wallace, F.A.; Miles, E.A; Calder, P.C; Newsholm, P. Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids2000, 35, 763-768.
61. Benoit, V.; Relic, B.; Leval, X.X.; Chariot, A.; Merville, M.P.; Bours, V. Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2. Oncogene2004, 23, 1631-1635.
62. Richards, J.A.; Brueggemeier, R.W. Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. J. Clin. Endocrinol. Metab.2003, 88, 2810–2816.
63. Kelley, D.S.; Taylor, P.C.; Nelson, G.J.; Schmidt, P.C.; Ferretti, A.; Erickson, K.L.; Yu, R.; Chandra, R.K.; Mackey, B.E. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids1999, 34, 317–324.
64. Wei, N.; Wang, B.; Zhang, Q.Y.; Mi, M.T.; Zhu, J.D.; Yu, X.P.; Yuan, J.L.; Chen, K.; Wang, J.; Chang, H. Effects of different dietary fatty acids on the fatty acid compositions and the expression of lipid metabolic-related genes in mammary tumor tissues of rats. Nutr. Cancer2008, 60, 810–825.
65. Serhan, C.N. Novel eicosanoid and docosanoid mediators: Resolvins, docosatrienes, and neuroprotectins. Curr. Opin. Clin. Nutr. Metab. Care 2005, 8, 115–121.
66. Serhan, C.N.; Arita, M.; Hong, S.; Gotlinger, K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids2004, 39, 1125–1132.
67. Weylandt, K.H.; Kang, J.X.; Wiedenmann, B.; Baumgart, D.C. Lipoxins and resolvins in inflammatory bowel disease. Inflamm. Bowel. Dis.2007, 13, 797–799.
68. Kang, J.X.; Weylandt, K.H. Modulation of inflammatory cytokines by omega-3 fatty acids. Subcell. Biochem.2008, 49, 133–143.
69. Calder, P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83, 1505S–1519S.
70. Zandi, R.; Larsen, A.B.; Andersen, P.; Stockhausen, M.T.; Poulsen, H.S. Mechanisms for oncogenic activation of the epidermal growth factor receptor. Cell Signal. 2007, 19, 2013–2023.
71. Corsetto, P.A.; Montorfano, G.; Zava, S.; Jovenitti, I.E.; Cremona, A.; Berra, B.; Rizzo, A.M. Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane. Lipids Health Dis. 2011, 10, 73.
72. Bhargava, R.; Gerald, W.L.; Li, A.R.; Pan, Q.; Lal, P.; Ladanyi, M.; Chen, B. EGFR gene amplification in breast cancer: Correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod. Pathol. 2005, 18, 1027–1033.
73. Hynes, N.E.; Stern, D.F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta1994, 1198, 165–184.
74. Tovey, S.M.; Brown, S.; Doughty, J.C.; Mallon, E.A.; Cooke, T.G.; Edwards, J. Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours. Br. J. Cancer2009, 100, 680–683.
75. Moasser, M.M. The oncogene HER2: Its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene2007, 26, 6469–6487.
76. Bollig-Fischer, A.; Dziubinski, M.; Boyer, A.; Haddad, R.; Giroux, C.N.; Ethier, S.P. HER-2 signaling, acquisition of growth factor independence, and regulation of biological networks associated with cell transformation. Cancer Res. 2010, 70, 7862–7873.
77. Yee, L.D.; Agarwal, D.; Rosol, T.J.; Lehman, A.; Tian, M.; Hatton, J.; Heestand, J.; Belury, M.A.; Clinton, S.K. The inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs. Mol. Nutr. Food Res.2013, 57, 320–327.
78. Truan, J.S.; Chen, J.M.; Thompson, L.U. Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen. Mol. Nutr. Food Res.2010, 54, 1414–1421.
79. Desvergne, B.; Wahli, W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr. Rev.1999, 20, 649–688.
80. Georgiadi, A.; Kersten, S. Mechanisms of gene regulation by fatty acids. Adv. Nutr.2012, 3, 127–134.
81. Gurnell, M.; Savage, D.B.; Chatterjee, V.K.; O’Rahilly, S. The metabolic syndrome: Peroxisome proliferator-activated receptor gamma and its therapeutic modulation. J. Clin. Endocrinol. Metab.2003, 88, 2412–2421.
82. Flachs, P.; Rossmeisl, M.; Bryhn, M.; Kopecky, J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin. Sci.2009, 116, 1–16.
83. Kliewer, S.A.; Sundseth, S.S.; Jones, S.A.; Brown, P.J.; Wisely, G.B.; Koble, C.S.; Devchand, P.; Wahli, W.; Willson, T.M.; Lenhard, J.M. et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA1997, 94, 4318–4323.
84. Clay, C.E.; Namen, A.M.; Atsumi, G.; Willingham, M.C.; High, K.P.; Kute, T.E.; Trimboli, A.J.; Fonteh, A.N.; Dawson, P.A.; Chilton, F.H. Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells. Carcinogenesis 1999, 20, 1905–1911.
85. Mueller, E.; Sarraf, P.; Tontonoz, P.; Evans, R.M.; Martin, K.J.; Zhang, M.; Fletcher, C.; Singer, S.; Spiegelman, B.M. Terminal differentiation of human breast cancer through PPAR gamma. Mol. Cell1998, 1, 465–470.
86. Barascu, A.; Besson, P.; Le, F.O.; Bougnoux, P.; Jourdan, M.L. CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells. Int. J. Biochem. Cell Biol.2006, 38, 196–208.
87. Jiang, W.; Zhu, Z.; McGinley, J.N.; El, B.K.; Manni, A.; Thompson, H.J. Identification of a molecular signature underlying inhibition of mammary carcinoma growth by dietary n-3 fatty acids. Cancer Res. 2012, 72, 3795–3806.
88. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007, 35, 495–516.
89. Jacobson, M.D.; Burne, J.F.; King, M.P.; Miyashita, T.; Reed, J.C.; Raff, M.C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature1993, 361, 365–369.
90. Van Slooten, H.J.; Clahsen, P.C.; van Dierendonck, J.H.; Duval, C.; Pallud, C.; Mandard, A.M.; obelle-Deroide, A.; van de Velde, C.J.; van de Vijver, M.J. Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy. Br. J. Cancer1996, 74, 78–85.
91. Oltvai, Z.N.; Milliman, C.L.; Korsmeyer, S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell1993, 74, 609–619.
92. Raisova, M.; Hossini, A.M.; Eberle, J.; Riebeling, C.; Wieder, T.; Sturm, I.; Daniel, P.T.; Orfanos, C.E.; Geilen, C.C. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J. Investig. Dermatol.2001, 117, 333–340.
93. Ion, G.; Akinsete, J.A.; Hardman, W.E. Maternal consumption of canola oil suppressed mammary gland tumorigenesis in C3(1) TAg mice offspring. BMC Cancer2010, 10, 81.
94. Vivanco, I.; Sawyers, C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer2002, 2, 489-501.
95. Bai, D.; Ueno, L.; Vogt, P.K. Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt. Int. J. Cancer2009, 125, 2863-2870.
96. Schley, P.D.; Jijon, H.B.; Robinson, L.E.; Field, C.J. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat.2005, 92, 187-195.
97. DeGraffenried, L.A.; Friedrichs, W.E.; Fulcher, L.; Fernandes, G; Silva, J.M.; Peralba, J.M.; Hidalgo, M. Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Ann. Oncol.2003, 14, 1051-1056.
98. Nicholson, K.M.; Anderson, N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 2002, 14, 381-395.
99. Hussain, A.R.; Ahmed, S.O.; Ahmed, M.; Khan, O.S.; Al, A.S.; Platanias, L.C.; Al-Kuraya, K.S.; Uddin, S. Cross-talk between NFκB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis. PLoS One 2012, 7, doi:10.1371/journal.pone.0039945.
100. Dolcet, X.; Llobet, D.; Pallares, J.; Matias-Guiu, X. NF-κB in development and progression of human cancer. Virchows Arch. 2005, 446, 475-482.
101. Wu, J.T.; Kral, J.G. The NF-κB/IκB signaling system: A molecular target in breast cancer therapy. J. Surg. Res.2005, 123, 158-169.
102. Mayo, M.W.; Wang, C.Y.; Cogswell, P.C.; Rogers-Graham, K.S.; Lowe, S.W.; Der, C.J.; Baldwin, A.S., Jr. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science1997, 278, 1812-1815.
103. Yerushalmi, R.; Woods, R.; Ravdin, P.M.; Hayes, M.M.; Gelmon, K.A. Ki67 in breast cancer: Prognostic and predictive potential. Lancet Oncol. 2010, 11, 174-183.
104. Scholzen, T.; Gerdes, J. The Ki-67 protein: From the known and the unknown. J. Cell. Physiol.2000, 182, 311-322.
105. Saggar, J.K.; Chen, J.; Corey, P.; Thompson, L.U. Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways. Mol. Nutr. Food Res. 2010, 54, 415-425.
106. Taftachi, R.; Ayhan, A.; Ekici, S.; Ergen, A.; Ozen, H. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: A comparison of PCNA and Ki-67. BJU Int. 2005, 95, 650-654.
107. Paunesku, T.; Mittal, S.; Protić, M.; Oryhon, J.; Korolev, S.V.; Joachimiak, A.; Woloschak, G.E. Proliferating cell nuclear antigen (PCNA): Ringmaster of the genome. Int. J. Radiat. Biol.2001, 77, 1007-1021.
108. Malkas, L.H.; Herbert, B.S.; bdel-Aziz, W.; Dobrolecki, L.E.; Liu, Y.; Agarwal, B.; Hoelz, D.; Badve, S.; Schnaper, L.; Arnold, R.J. et al. A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc. Natl. Acad. Sci. USA2006, 103, 19472-19477.
109. Strzalka, W.; Ziemienowicz, A. Proliferating cell nuclear antigen (PCNA): A key factor in DNA replication and cell cycle regulation. Ann. Bot.2011, 107, 1127–1140.
110. Olivo, S.E.; Hilakivi-Clarke, L. Opposing effects of prepubertal low- and high-fat n-3 polyunsaturated fatty acid diets on rat mammary tumorigenesis. Carcinogenesis2005, 26, 1563–1572.
111. Kim, I.S.; Baek, S.H. Mouse models for breast cancer metastasis. Biochem. Biophys. Res. Commun.2010, 394, 443–447.
112. Karmali, R.A.; Marsh, J.; Fuchs, C. Effect of omega-3 fatty acids on growth of a rat mammary tumor. J. Natl. Cancer Inst.1984, 73, 457–461.
113. Gonzalez, M.J.; Schemmel, R.A.; Gray, J.I.; Dugan, L., Jr.; Sheffield, L.G.; Welsch, C.W. Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: Relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis1991, 12, 1231–1235.
114. Hubbard, N.E.; Lim, D.; Erickson, K.L. Alteration of murine mammary tumorigenesis by dietary enrichment with n-3 fatty acids in fish oil. Cancer Lett. 1998, 124, 1–7.
115. Yee, L.D.; Young, D.C.; Rosol, T.J.; Vanbuskirk, A.M.; Clinton, S.K. Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone. J. Nutr.2005, 135, 983–988.
116. MacLennan, M.B.; Clarke, S.E.; Perez, K.; Wood, G.A.; Muller, W.J.; Kang, J.X.; Ma, D.W. Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids. J. Nutr. Biochem.2013, 24, 388–395.
117. Dankort, D.; Maslikowski, B.; Warner, N.; Kanno, N.; Kim, H.; Wang, Z.; Moran, M.F.; Oshima, R.G.; Cardiff, R.D.; Muller, W.J. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: Implications for human breast cancer. Mol. Cell Biol.2001, 21, 1540–1551.
118. Yee, L.D.; Lester, J.L.; Cole, R.M.; Richardson, J.R.; Hsu, J.C.; Li, Y.; Lehman, A.; Belury, M.A.; Clinton, S.K. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Am. J. Clin. Nutr.2010, 91, 1185–1194.
119. Luijten, M.; Verhoef, A.; Dormans, J.A.; Beems, R.B.; Cremers, H.W.; Nagelkerke, N.J.; Adlercreutz, H.; Penalvo, J.L.; Piersma, A.H. Modulation of mammary tumor development in Tg.NK (MMTV/c-neu) mice by dietary fatty acids and life stage-specific exposure to phytoestrogens. Reprod. Toxicol.2007, 23, 407–413.
120. Yuri, T.; Danbara, N.; Tsujita-Kyutoku, M.; Fukunaga, K.; Takada, H.; Inoue, Y.; Hada, T.; Tsubura, A. Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid. Nutr. Cancer2003, 45, 211–217.
121. Rose, D.P.; Connolly, J.M. Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res. 1990, 50, 7139–7144.
122. Grammatikos, S.I.; Subbaiah, P.V.; Victor, T.A.; Miller, W.M. n-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. Br. J. Cancer1994, 70, 219–227.
123. Kachhap, S.K.; Dange, P.P.; Santani, R.H.; Sawant, S.S.; Ghosh, S.N. Effect of omega-3 fatty acid (docosahexanoic acid) on BRCA1 gene expression and growth in MCF-7 cell line. Cancer Biother. Radiopharm.2001, 16, 257-263.
124. Chajes, V.; Sattler, W.; Stranzl, A.; Kostner, G.M. Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: Relationship to peroxides and vitamin-E. Breast Cancer Res. Treat.1995, 34, 199-212.
125. Chamras, H.; Ardashian, A.; Heber, D.; Glaspy, J.A. Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J. Nutr. Biochem.2002, 13, 711-716.
126. Rose, D.P.; Connolly, J.M.; Coleman, M. Effect of ω-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice. Clin. Cancer Res.1996, 2, 1751-1756.
127. Arterburn, L.M.; Hall, E.B.; Oken, H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr.2006, 83, 1467S-1476S.
128. Harper, C.R.; Edwards, M.J.; DeFilippis, A.P.; Jacobson, T.A. Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J. Nutr.2006, 136, 83-87.
129. Pawlosky, R.J.; Hibbeln, J.R.; Novotny, J.A.; Salem, N., Jr. Physiological compartmental analysis of α-linolenic acid metabolism in adult humans. J. Lipid Res.2001, 42, 1257-1265.
130. Brenna, J.T. Efficiency of conversion of α-linolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab Care2002, 5, 127-132.
131. Ezaki, O.; Takahashi, M.; Shigematsu, T.; Shimamura, K.; Kimura, J.; Ezaki, H.; Gotoh, T. Long-term effects of dietary α-linolenic acid from perilla oil on serum fatty acids composition and on the risk factors of coronary heart disease in Japanese elderly subjects. J. Nutr. Sci. Vitaminol.1999, 45, 759-772.
132. Ghafoorunissa Vani, A.; Laxmi, R.; Sesikeran, B. Effects of dietary α-linolenic acid from blended oils on biochemical indices of coronary heart disease in Indians. Lipids2002, 37, 1077-1086.
133. Klein, V.; Chajes, V.; Germain, E.; Schulgen, G; Pinault, M.; Malvy, D.; Lefrancq, T.; Fignon, A.; Le, F.O.; Lhuillery, C; Bougnoux, P. Low α-linolenic acid content of adipose breast tissue is associated with an increased risk of breast cancer. Eur. J. Cancer2000, 36, 335-340.
134. Bougnoux, P.; Koscielny, S.; Chajes, V.; Descamps, P.; Couet, C; Calais, G. α-Linolenic acid content of adipose breast tissue: A host determinant of the risk of early metastasis in breast cancer. Br. J. Cancer1994, 70, 330-334.
135. Fritsche, K.L.; Johnston, P.V. Effect of dietary α-linolenic acid on growth, metastasis, fatty acid profile and prostaglandin production of two murine mammary adenocarcinomas. J. Nutr.1990, 120, 1601-1609.
136. Hardman, W.E. Dietary canola oil suppressed growth of implanted MDA-MB 231 human breast tumors in nude mice. Nutr. Cancer2007, 57, 177-183.
137. Mabasa, L.; Cho, K.; Walters, M.W.; Bae, S.; Park, C.S. Maternal dietary canola oil suppresses growth of mammary carcinogenesis in female rat offspring. Nutr. Cancer2013, 65, 695-701.
138. Menendez, J.A.; Vazquez-Martin, A.; Ropero, S.; Colomer, R.; Lupu, R. HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, α-linolenic acid (ALA; 18:3n-3), in breast cancer cells: The “fat features” of the “Mediterranean diet” as an “anti-HER2 cocktail”. Clin. Transl. Oncol.2006, 8, 812–820.
139. Menendez, J.A.; Ropero, S.; Lupu, R.; Colomer, R. Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells. Ann. Oncol.2004, 15, 1719–1721.
140. Mason, J.K.; Fu, M.H.; Chen, J.; Yu, Z.; Thompson, L.U. Dietary flaxseed-trastuzumab interactive effects on the growth of HER2-overexpressing human breast tumors (BT-474). Nutr. Cancer2013, 65, 451–459.
141. Hirose, M.; Masuda, A.; Ito, N.; Kamano, K.; Okuyama, H. Effects of dietary perilla oil, soybean oil and safflower oil on 7,12-dimethylbenz (a) anthracene (DMBA) and 1,2-dimethyl-hydrazine (DMH)-induced mammary gland and colon carcinogenesis in female SD rats. Carcinogenesis1990, 11, 731–735.
142. Chiu, L.C.; Wan, J.M. Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression. Cancer Lett. 1999, 145, 17–27.
143. Senzaki, H.; Iwamoto, S.; Ogura, E.; Kiyozuka, Y.; Arita, S.; Kurebayashi, J.; Takada, H.; Hioki, K.; Tsubura, A. Dietary effects of fatty acids on growth and metastasis of KPL-1 human breast cancer cells in vivo and in vitro. Anticancer Res. 1998, 18, 1621–1627.
144. Sauer, L.A.; Dauchy, R.T.; Blask, D.E.; Krause, J.A.; Davidson, L.K.; Dauchy, E.M. Eicosapentaenoic acid suppresses cell proliferation in MCF-7 human breast cancer xenografts in nude rats via a pertussis toxin-sensitive signal transduction pathway. J. Nutr.2005, 135, 2124–2129.
145. Chambrier, C.; Bastard, J.P.; Rieusset, J.; Chevillotte, E.; Bonnefont-Rousselot, D.; Therond, P.; Hainque, B.; Riou, J.P.; Laville, M.; Vidal, H. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes. Res.2002, 10, 518–525.
146. Kang, K.S.; Wang, P.; Yamabe, N.; Fukui, M.; Jay, T.; Zhu, B.T. Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One 2010, 5, doi:10.1371/journal.pone.0010296.
147. Blanckaert, V.; Ulmann, L.; Mimouni, V.; Antol, J.; Brancquart, L.; Chenais, B. Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231. Int. J. Oncol.2010, 36, 737–742.
148. Chiu, L.C.; Wong, E.Y.; Ooi, V.E. Docosahexaenoic acid from a cultured microalga inhibits cell growth and induces apoptosis by upregulating Bax/Bcl-2 ratio in human breast carcinoma MCF-7 cells. Ann. N. Y. Acad. Sci.2004, 1030, 361–368.
149. Tsujita-Kyutoku, M.; Yuri, T.; Danbara, N.; Senzaki, H.; Kiyozuka, Y.; Uehara, N.; Takada, H.; Hada, T.; Miyazawa, T.; Ogawa, Y. et al. Conjugated docosahexaenoic acid suppresses KPL-1 human breast cancer cell growth in vitro and in vivo: Potential mechanisms of action. Breast Cancer Res. 2004, 6, R291–R299.
150. Connolly, J.M.; Gilhooly, E.M.; Rose, D.P. Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. Nutr. Cancer1999, 35, 44–49.
151. Jourdan, M.L.; Maheo, K.; Barascu, A.; Goupille, C.; de Latour, M.P.; Bougnoux, P.; Rio, P.G. Increased BRCA1 protein in mammary tumours of rats fed marine omega-3 fatty acids. Oncol. Rep.2007, 17, 713–719.
152. Bernard-Gallon, D.J.; Vissac-Sabatier, C.; ntoine-Vincent, D.; Rio, P.G.; Maurizis, J.C.; Fustier, P.; Bignon, Y.J. Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines. Br. J. Nutr.2002, 87, 281–289.
153. Bougnoux, P.; Chajes, V.; Germain, E.; Hubert, B.; Lhuillery, C.; Le, F.O.; Body, G.; Calais, G. Cytotoxic drug efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma. Lipids1999, 34, S109.
154. Bougnoux, P.; Hajjaji, N.; Ferrasson, M.N.; Giraudeau, B.; Couet, C.; Le, F.O. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: A phase II trial. Br. J. Cancer2009, 101, 1978–1985.
155. Rahman, M.M.; Veigas, J.M.; Williams, P.J.; Fernandes, G. DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA. Breast Cancer Res. Treat.2013, 141, 341–352.